Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
3.580
+0.050 (1.42%)
Oct 30, 2026, 12:09 PM EDT - Market open
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of $140.57 million as of October 30, 2026. Its market cap has increased by 1.44% in one year.
Market Cap
140.57M
Enterprise Value
62.04M
1-Year Change
1.44%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since the IPO on June 16, 2021, Molecular Partners AG's market cap has decreased from $683.35M to $140.57M, a decrease of -79.43%. That is a compound annual growth rate of -25.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 140.57M | -12.22% |
| Dec 30, 2025 | 160.13M | -2.96% |
| Dec 30, 2024 | 165.01M | 22.94% |
| Dec 29, 2023 | 134.22M | -38.09% |
| Dec 30, 2022 | 216.81M | -65.56% |
| Dec 30, 2021 | 629.47M | -7.89% |
| Jun 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NervGen Pharma | 153.76M |
| Upstream Bio | 150.07M |
| Canton Strategic Holdings | 148.21M |
| MacroGenics | 143.33M |
| Acumen Pharmaceuticals | 143.19M |
| Veraxa Biotech AG | 141.41M |
| Atrium Therapeutics | 140.27M |
| Codexis | 140.17M |